
A new clinical trial tests a combo of #osimertinib, platinum and etoposide chemotherapy in patients with EGFR-mutant #LungCancer, and reveals how lineage plasticity shapes the risk of #SCLC transformation and drug resistance. @jmchan88 @MSKCancerCenter scim.ag/4ewEoYg
















